Huang, L. Et Al. 2023. Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial. Influenza and other Respiratory Viruses , vol.17, no.7 .

Huang, L., Schibler, A., Huang, Y., Tai, A., Chi, H., Chieng, C., ... Wang, J.(2023). Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial. Influenza and other Respiratory Viruses , vol.17, no.7.

Huang, Li-Min Et Al. "Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial," Influenza and other Respiratory Viruses , vol.17, no.7, 2023

Huang, Li-Min Et Al. "Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial." Influenza and other Respiratory Viruses , vol.17, no.7, 2023

Huang, L. Et Al. (2023) . "Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial." Influenza and other Respiratory Viruses , vol.17, no.7.

@article{article, author={Li-Min Huang Et Al. }, title={Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial}, journal={Influenza and other Respiratory Viruses}, year=2023}